1.Comparison of Quantitation of Cytomegalovirus DNA by Real-Time PCR in Whole Blood with the Cytomegalovirus Antigenemia Assay.
Seonhee KWON ; Bo Kyeung JUNG ; Sun Young KO ; Chang Kyu LEE ; Yunjung CHO
Annals of Laboratory Medicine 2015;35(1):99-104
BACKGROUND: Quantitation of cytomegalovirus (CMV) DNA using real-time PCR has been utilized for monitoring CMV infection. However, the CMV antigenemia assay is still the 'gold standard' assay. There are only a few studies in Korea that compared the efficacy of use of real-time PCR for quantitation of CMV DNA in whole blood with the antigenemia assay, and most of these studies have been limited to transplant recipients. METHOD: 479 whole blood samples from 79 patients, falling under different disease groups, were tested by real-time CMV DNA PCR using the Q-CMV real-time complete kit (Nanogen Advanced Diagnostic S.r.L., Italy) and CMV antigenemia assay (CINA Kit, ArgeneBiosoft, France), and the results were compared. Repeatedly tested patients were selected and their charts were reviewed for ganciclovir therapy. RESULTS: The concordance rate of the two assays was 86.4% (Cohen's kappa coefficient value=0.659). Quantitative correlation between the two assays was a moderate (r=0.5504, P<0.0001). Among 20 patients tested repeatedly with the two assays, 13 patients were transplant recipients and treated with ganciclovir. Before treatment, CMV was detected earlier by real-time CMV DNA PCR than the antigenemia assay, with a median difference of 8 days. After treatment, the antigenemia assay achieved negative results earlier than real-time CMV DNA PCR with a median difference of 10.5 days. CONCLUSIONS: Q-CMV real-time complete kit is a useful tool for early detection of CMV infection in whole blood samples in transplant recipients.
Antiviral Agents/therapeutic use
;
Cytomegalovirus/*genetics
;
Cytomegalovirus Infections/drug therapy/pathology/virology
;
DNA, Viral/*blood/metabolism
;
Ganciclovir/therapeutic use
;
Humans
;
*Immunoassay
;
Organ Transplantation
;
Phosphoproteins/genetics/immunology/*metabolism
;
*Real-Time Polymerase Chain Reaction
;
Viral Matrix Proteins/genetics/immunology/*metabolism
;
Virology/*methods
2.Cytomegalovirus Ventriculoencephalitis after Unrelated Double Cord Blood Stem Cell Transplantation with an Alemtuzumab-containing Preparative Regimen for Philadelphia-positive Acute Lymphoblastic Leukemia.
Seok LEE ; Si Hyun KIM ; Su Mi CHOI ; Dong Gun LEE ; Sung Yong KIM ; Jong Wook LEE ; Woo Sung MIN ; Wan Shik SHIN ; Chun Choo KIM
Journal of Korean Medical Science 2010;25(4):630-633
Despite the prophylaxis and preemptive strategies using potent antiviral agents, cytomegalovirus (CMV) remains a major infectious cause of morbidity and mortality in allogeneic stem cell transplantation (SCT) recipients. Delayed immune reconstitution after SCT, such as cord blood and T-cell depleted SCT with the use of alemtuzumab, has been associated with an increased frequency of CMV disease as well as CMV reactivation. CMV disease involving central nervous system is an unusual presentation in the setting of SCT. We report a case of CMV ventriculoencephalitis after unrelated double cord blood SCT with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia.
Antibodies, Monoclonal/pharmacology/*therapeutic use
;
Antibodies, Monoclonal, Humanized
;
Antibodies, Neoplasm/pharmacology/*therapeutic use
;
Antineoplastic Agents/pharmacology/*therapeutic use
;
Cord Blood Stem Cell Transplantation/*adverse effects
;
Cytomegalovirus/drug effects
;
Cytomegalovirus Infections/*drug therapy/*etiology/physiopathology
;
*Encephalitis/etiology/pathology/virology
;
Fatal Outcome
;
Humans
;
Male
;
*Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications/drug therapy/virology
;
Transplantation Conditioning/methods
3.Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report.
Jihyun AN ; Joo Ho LEE ; Hyojeong LEE ; Eunsil YU ; Dan Bi LEE ; Ju Hyun SHIM ; Sunyoung YOON ; Yumi LEE ; Soeun PARK ; Han Chu LEE
The Korean Journal of Hepatology 2012;18(1):84-88
Hepatitis A virus (HAV) infections occur predominantly in children, and are usually self-limiting. However, 75-95% of the infections in adults are symptomatic (mostly with jaundice), with the illness symptoms usually persisting for a few weeks. Atypical manifestations include relapsing hepatitis, prolonged cholestasis, and complications involving renal injury. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, drug-induced hypersensitivity reaction characterized by skin rash, fever, lymph-node enlargement, and internal organ involvement. We describe a 22-year-old male who presented with acute kidney injury and was diagnosed with prolonged cholestatic hepatitis A. The patient also developed DRESS syndrome due to antibiotic and/or antiviral treatment. To our knowledge, this is the first report of histopathologically confirmed DRESS syndrome due to antibiotic and/or antiviral treatment following HAV infection with cholestatic features and renal injury.
Acute Kidney Injury/diagnosis
;
Anti-Bacterial Agents/*adverse effects/therapeutic use
;
Cefotaxime/adverse effects/therapeutic use
;
Cholestasis/complications/*diagnosis
;
Cytomegalovirus/genetics
;
Cytomegalovirus Infections/drug therapy/virology
;
DNA, Viral/analysis
;
Eosinophilia/etiology
;
Exanthema/*chemically induced/pathology
;
Ganciclovir/therapeutic use
;
Hepatitis A/complications/*diagnosis/drug therapy
;
Humans
;
Hydrocortisone/therapeutic use
;
Immunoglobulins/therapeutic use
;
Male
;
Syndrome
;
Young Adult